Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIVJoel E. Gallant, Andrew Cheng, Biao Lu et al.|New England Journal of Medicine|2006Cited by 886
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trialFrançois Raffi, Anton Pozniak, Abdel G. Babiker et al.|The Lancet|2014Cited by 175
A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infectionRichard Elion, Javier Szwarcberg, Jean‐Michel Molina et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 41